Stella Pharma Corporation (TYO:4888)

Stella Pharma Revenue

In the fiscal year ending March 31, 2026, Stella Pharma had annual revenue of 323.00M JPY, down -66.39%. Stella Pharma had revenue of 62.00M in the quarter ending March 31, 2026, a decrease of -91.23%.

• Revenue: 323.00M
• Revenue Growth: -66.39%
• P/S Ratio: 36.01
• Revenue / Employee: 7.51M
• Employees: 43
• Market Cap: 11.63B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	323.00M	-638.00M	-66.39%
Mar 31, 2025	961.00M	692.00M	257.25%
Mar 31, 2024	269.00M	40.00M	17.47%
Mar 31, 2023	229.00M	129.00M	129.00%
Mar 31, 2022	100.00M	-105.00M	-51.22%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 30, 2026

Data Sources Report a data error